T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
1126
DELISTED
Avadel Pharmaceuticals
AVDL
| $20.3M | ﹤0.01% |
1,131,500
+3,500
| +0.3% | +$54.8K |
|
|
ATW
1127
DELISTED
Atwood Oceanics
ATW
| $20.3M | ﹤0.01% |
723,530
+6,700
| +0.9% | +$199K |
|
1128
Alamo Group
ALG
$1.99B
| $20.3M | ﹤0.01% |
321,810
-10
| -0% | -$518 |
|
1129
Petrobras
PBR
$115B
| $20.3M | ﹤0.01% |
3,379,402
-3,113,400
| -48% | -$19.8M |
|
|
THR
1130
DELISTED
Thermon Group Holdings
THR
| $20.3M | ﹤0.01% |
841,370
+7,460
| +0.9% | +$172K |
|
|
CAM
1131
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $20.2M | ﹤0.01% |
447,560
-1,378,717
| -75% | -$62.9M |
|
1132
Equity Lifestyle Properties
ELS
$12.6B
| $20.1M | ﹤0.01% |
732,680
+109,600
| +18% | +$3M |
|
|
SEMG
1133
DELISTED
SEMGROUP CORPORATION
SEMG
| $19.9M | ﹤0.01% |
245,000
-2,400
| -1% | -$172K |
|
1134
Molson Coors Class B
TAP
$7.85B
| $19.8M | ﹤0.01% |
265,538
-400
| -0.2% | -$30.1K |
|
|
EFOR
1135
Everforth Inc
EFOR
$1.37B
| $19.7M | ﹤0.01% |
513,990
-443,390
| -46% | -$16.2M |
|
|
JWN
1136
DELISTED
Nordstrom
JWN
| $19.6M | ﹤0.01% |
244,419
+7,280
| +3% | +$576K |
|
1137
Watts Water Technologies
WTS
$12.8B
| $19.4M | ﹤0.01% |
352,000
+340,950
| +3,086% | +$19.4M |
|
|
MDVN
1138
DELISTED
MEDIVATION, INC.
MDVN
| $19.4M | ﹤0.01% |
300,134
+138,200
| +85% | +$7.92M |
|
1139
Clean Harbors
CLH
$16.9B
| $19.3M | ﹤0.01% |
339,930
+30,130
| +10% | +$1.56M |
|
1140
Live Nation Entertainment
LYV
$43.3B
| $19.1M | ﹤0.01% |
757,500
+29,600
| +4% | +$747K |
|
|
EGL
1141
DELISTED
Engility Holdings, Inc.
EGL
| $19.1M | ﹤0.01% |
+635,444
| New | +$25.4M |
|
|
CAMP
1142
DELISTED
CalAmp Corp.
CAMP
| $19.1M | ﹤0.01% |
51,248
+50,739
| +9,968% | +$20.9M |
|
1143
Utah Medical Products
UTMD
$230M
| $19.1M | ﹤0.01% |
318,390
+850
| +0.3% | +$50K |
|
1144
U-Haul Holding Co
UHAL
$14.4B
| $19M | ﹤0.01% |
576,000
+38,000
| +7% | +$1.17M |
|
1145
NVIDIA
NVDA
$5.46T
| $19M | ﹤0.01% |
36,356,640
+2,022,400
| +6% | +$1.08M |
|
1146
MarketAxess Holdings
MKTX
$5.72B
| $19M | ﹤0.01% |
229,300
+18,700
| +9% | +$1.48M |
|
1147
Avis
CAR
$4.84B
| $19M | ﹤0.01% |
321,800
+8,000
| +3% | +$488K |
|
1148
Mohawk Industries
MHK
$9.42B
| $19M | ﹤0.01% |
102,181
| – | – |
|
1149
Tyson Foods
TSN
$19.8B
| $18.9M | ﹤0.01% |
492,679
+9,595
| +2% | +$384K |
|
1150
FMC
FMC
$1.27B
| $18.9M | ﹤0.01% |
380,020
+4,365
| +1% | +$227K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.